Description
Biochem Pharma: A Leader in the Canadian Biotechnology Industry: Abstract
Real options and Growth options in the biotechnology sector.
Biochem Pharma: A Leader in the Canadian Biotechnology Industry
8,00 $ – 50,00 $
CASE STUDY. Real options and Growth options in the biotechnology sector.
Additional information
| Year | |
|---|---|
| Appendix | |
| Editor | |
| Format | |
| Industry | |
| Institution | |
| Language | |
| License | |
| Number of Pages | |
| Teaching Notes | |
| Case centre numbering | |
| Size | |
| Product Type |
You must be logged in to post a review.
Related products
-
Cascades Tissue Group: Sustainable Growth?
8,00 $ – 50,00 $CASE STUDY. In October 2006, Ms. Suzanne Blanchet, President and Chief Executive Officer of Cascades Tissue Group (CTG), was pondering how much weight should be given to products sold under the CTG brand compared to those sold under distributors’ or retailers’ private labels.
-
China’s Rare Earth and Japan
8,00 $ – 50,00 $CASE STUDY. The case depicts the subtleties of the China-Japan politico-economic relations and discusses the involvement of other important actors, such as the US and the EU, in the struggle for resources.
-
ABC Insurance
8,00 $ – 50,00 $CASE STUDY. Through a complete reorganization of work, she hopes to counter problems related to customer retention and finding new clients.
Reviews
There are no reviews yet.